@article{be1836c0930b4076866e056705e6ebac,
title = "Reply to Koehler et al",
author = "Maya Beganovic and Luther, {Megan K.} and Rice, {Louis B.} and Arias, {Cesar A.} and Rybak, {Michael J.} and Laplante, {Kerry L.}",
note = "Funding Information: received research funding or acted as an advisor or consultant for Merck, Davol/BARD, Actavis, Melinta Therapeutics, the Medicines Company, and Pfizer. C. A. is employed by the University of Texas Health Science Center; has received grants from Merck and MeMed Diagnostics; and has received royalties from UpToDate and Harrison Principal of Internal Medicine. All other authors reported no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.",
year = "2019",
month = aug,
day = "16",
doi = "10.1093/cid/ciz057",
language = "English (US)",
volume = "69",
pages = "901--902",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",
}